GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors BESKROVNAYA, Oxana, CELATKA, Cassandra, XIANG, Yibin, LEONARD, John, BOURQUE, Elyse, SKERLJ, Renato, MAKINO, Elina, METZ, Markus, NATOLI, Thomas, GOOD, Andrew, CABRERA-SALAZAR, Mario, A, HIRTH, Bradford, CHENG, Seng, H, SCHEULE, Ronald, K, HUSSON, Herve, MARSHALL, John, ZHAO, Zhong, JANCSICS, Katherine
Format Patent
LanguageEnglish
French
German
Published 23.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
AbstractList The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
Author CHENG, Seng, H
LEONARD, John
XIANG, Yibin
NATOLI, Thomas
HIRTH, Bradford
CELATKA, Cassandra
JANCSICS, Katherine
GOOD, Andrew
SCHEULE, Ronald, K
MARSHALL, John
BOURQUE, Elyse
ZHAO, Zhong
MAKINO, Elina
SKERLJ, Renato
BESKROVNAYA, Oxana
METZ, Markus
CABRERA-SALAZAR, Mario, A
HUSSON, Herve
Author_xml – fullname: BESKROVNAYA, Oxana
– fullname: CELATKA, Cassandra
– fullname: XIANG, Yibin
– fullname: LEONARD, John
– fullname: BOURQUE, Elyse
– fullname: SKERLJ, Renato
– fullname: MAKINO, Elina
– fullname: METZ, Markus
– fullname: NATOLI, Thomas
– fullname: GOOD, Andrew
– fullname: CABRERA-SALAZAR, Mario, A
– fullname: HIRTH, Bradford
– fullname: CHENG, Seng, H
– fullname: SCHEULE, Ronald, K
– fullname: HUSSON, Herve
– fullname: MARSHALL, John
– fullname: ZHAO, Zhong
– fullname: JANCSICS, Katherine
BookMark eNrjYmDJy89L5WRQcfcJdfYPjvRxdg1y9PV0cVUIjvQL8XAMdlXw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BRhaWpiYWJk6GxkQoAQBFsSTZ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate GLUCOSYLCERAMID-SYNTHASE-HEMMER
INHIBITEURS DE SYNTHASE DE GLUCOSYLCÉRAMIDE
ExternalDocumentID EP2895484B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2895484B13
IEDL.DBID EVB
IngestDate Fri Aug 23 06:55:33 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2895484B13
Notes Application Number: EP20130765893
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220223&DB=EPODOC&CC=EP&NR=2895484B1
ParticipantIDs epo_espacenet_EP2895484B1
PublicationCentury 2000
PublicationDate 20220223
PublicationDateYYYYMMDD 2022-02-23
PublicationDate_xml – month: 02
  year: 2022
  text: 20220223
  day: 23
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Genzyme Corporation
RelatedCompanies_xml – name: Genzyme Corporation
Score 3.391003
Snippet The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220223&DB=EPODOC&locale=&CC=EP&NR=2895484B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTaxSEw0NgctajcDdlASTZJ0Lc2TUnQtUpJBZ5UYpaYlgRfI-pl5hJp4RZhGMDFkwvbCgM8JLQcfjgjMUcnA_F4CLq8LEINYLuC1lcX6SZlAoXx7txBbFzVo79gIhIzVXJxsXQP8Xfyd1ZydgSw1vyBbYL8C2DY3cQJ2lFhBrWjQMfuuYU6gTSkFyDWKmyADWwDQsLwSIQam1DxhBk5n2MVrwgwcvtD5biATmvWKRRhU3H1Cnf2DI32cXYMcfT1dXBWCI_1CPByDXRU8_Tw8nTxD_IOCRRkU3FxDnD10gdbFw70W7xoAd5ixGAMLsMefKsGgYJkGOi7WwCDJyDDVxCTZ0CLZLMnQINHCDFgdp1qkmEoySOI0RgqPnDQDFyiAwDuyjWUYWEqKSlNlgXVqSZIcODQA_8h2zQ
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTaxSEw0NgctajcDdlASTZJ0Lc2TUnQtUpJBZ5UYpaYlgRfI-pl5hJp4RZhGMDFkwvbCgM8JLQcfjgjMUcnA_F4CLq8LEINYLuC1lcX6SZlAoXx7txBbFzVo79gIhIzVXJxsXQP8Xfyd1ZydgSw1vyBbYL8C2DY3cQJ2lFjNQYfzglpOYU6gTSkFyDWKmyADWwDQsLwSIQam1DxhBk5n2MVrwgwcvtD5biATmvWKRRhU3H1Cnf2DI32cXYMcfT1dXBWCI_1CPByDXRU8_Tw8nTxD_IOCRRkU3FxDnD10gdbFw70W7xoAd5ixGAMLsMefKsGgYJkGOi7WwCDJyDDVxCTZ0CLZLMnQINHCDFgdp1qkmEoySOI0RgqPnDwDp0eIr0-8j6eftzQDFyiwwLuzjWUYWEqKSlNlgfVrSZIcOGQAtiF5ug
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=GLUCOSYLCERAMIDE+SYNTHASE+INHIBITORS&rft.inventor=BESKROVNAYA%2C+Oxana&rft.inventor=CELATKA%2C+Cassandra&rft.inventor=XIANG%2C+Yibin&rft.inventor=LEONARD%2C+John&rft.inventor=BOURQUE%2C+Elyse&rft.inventor=SKERLJ%2C+Renato&rft.inventor=MAKINO%2C+Elina&rft.inventor=METZ%2C+Markus&rft.inventor=NATOLI%2C+Thomas&rft.inventor=GOOD%2C+Andrew&rft.inventor=CABRERA-SALAZAR%2C+Mario%2C+A&rft.inventor=HIRTH%2C+Bradford&rft.inventor=CHENG%2C+Seng%2C+H&rft.inventor=SCHEULE%2C+Ronald%2C+K&rft.inventor=HUSSON%2C+Herve&rft.inventor=MARSHALL%2C+John&rft.inventor=ZHAO%2C+Zhong&rft.inventor=JANCSICS%2C+Katherine&rft.date=2022-02-23&rft.externalDBID=B1&rft.externalDocID=EP2895484B1